{
  "timestamp": "2025-03-11T19:32:16.511Z",
  "endpoint": "handleGuidelines",
  "prompt": {
    "prompt": "Please identify ONLY the guidelines that DIRECTLY address the management of this specific clinical issue. The guidelines must contain specific recommendations or protocols for managing this exact condition.\n\nRules:\n- Select ONLY guidelines that have this issue as their primary focus\n- EXCLUDE guidelines that only mention the issue in passing\n- EXCLUDE guidelines that focus on different conditions\n- Return ONLY the exact filenames of relevant guidelines\n- List each filename on a new line\n- Do not add any additional text or explanations\n\nFor example, for 'Previous Caesarean Section', ONLY return guidelines specifically about VBAC or birth after caesarean.\nFor 'Obesity in Pregnancy', ONLY return guidelines specifically about managing obesity in pregnancy.\n\nIssue: BMI 28\n\nAvailable guidelines:\nGTG 2014 - Endometrial Hyperplasia.txt: The clinical guideline for the management of endometrial hyperplasia emphasizes the importance of identifying and monitoring risk factors, utilizing the WHO classification for diagnosis, and implementing appropriate surveillance methods such as endometrial sampling and hysteroscopy. Progestogens, particularly the levonorgestrel-releasing intrauterine system (LNG-IUS), are recommended for managing hyperplasia without atypia, with surgical options considered in certain cases. Total hysterectomy is advised for atypical hyperplasia, especially for women no longer requiring fertility. The guideline also addresses specific considerations for women on hormone replacement therapy, adjuvant breast cancer treatment, and tamoxifen therapy. Regular surveillance and follow-up biopsies are essential for monitoring disease regression and progression. Future research recommendations and auditable topics are highlighted, along with useful links and support groups for further information and support.\nBJOG - 2017 -  Management of Breech Presentation.txt: The clinical guideline on the Management of Breech Presentation provides recommendations for the management of breech presentation at term. It suggests offering external cephalic version (ECV) to women with breech presentation unless contraindicated, and counseling on the risks and benefits of ECV and implications for mode of delivery. The guideline discusses the risks and benefits of planned vaginal breech delivery versus planned caesarean section, highlighting the reduction in perinatal mortality with caesarean section but also the risks associated with future pregnancies. Skilled intrapartum care and adherence to a management protocol are emphasized for safe vaginal breech delivery. Research recommendations and audit topics are also included.\nRCOG - Birth After Previous Caesarean Section - 2015.txt: The clinical guideline on Birth After Previous Caesarean Birth recommends antenatal care, offering planned VBAC to most women with a single previous lower segment caesarean delivery. The success rate of VBAC is 72-75%, with previous vaginal delivery being a predictor of success. Induction or augmentation of labour increases the risk of uterine rupture. ERCS should be conducted after 39+0 weeks with antibiotics and thromboprophylaxis given. VBAC may not be suitable for pregnancies with certain complications. Consideration should be given to attempting VBAC in women with multiple future pregnancies. The guideline emphasizes the importance of individualized antenatal care and documented counseling by a member of the maternity team.\nUHSussex - MP046 - Management of Breech and ECV.txt: Diagnosis and Presentation:\n- Breech presentation is defined as a fetus in longitudinal lie with the buttocks, legs, or feet in the lower uterine segment closest to the cervix.\n- Types of breech presentation include frank or extended breech, complete or flexed breech, footling breech, and kneeling breech.\n- Pregnant individuals with confirmed breech presentation should be offered external cephalic version (ECV) at 36-37 weeks of gestation.\n- Absolute contraindications for ECV include conditions like placenta previa, antepartum hemorrhage, severe preeclampsia, and abnormal fetal dopplers.\n- Risk factors for planned vaginal breech birth include hyperextended neck on ultrasound, high or low estimated fetal weight, footling presentation, and evidence of antenatal fetal compromise.\n\nTreatment and Management:\n- ECV should be performed by trained obstetricians and monitored for complications.\n- Pregnant individuals declining ECV or with persistent breech presentation should be informed of birth options such as planned caesarean section or vaginal breech birth.\n- Pregnant individuals opting for elective LSCS for breech presentation should be informed about timing and potential risks.\n- Pregnant individuals choosing vaginal breech birth should have antenatal assessment and be referred to appropriate clinics for care.\n- Multidisciplinary team approach is recommended for planned vaginal breech birth.\n- Continuous CTG monitoring is recommended in established labor.\n- Maternal observations should be performed regularly throughout labor.\n- Intravenous cannula is recommended on admission for individuals with anticipated difficulty with IV access.\n- Upright position and mobility in labor should be encouraged.\n- Full range of pain relief options should be available.\n- Birthing individuals should feel calm, in control, and supported during labor and birth.\n\nMonitoring Requirements:\n- Continuous CTG monitoring in established labor.\n\nContraindications and Cautions:\n- Absolute contraindications for ECV include placenta previa, antepartum hemorrhage, severe preeclampsia, and abnormal fetal dopplers.\n- Risk factors for planned vaginal breech birth include hyperextended neck on ultrasound, high or low estimated fetal weight, footling presentation, and evidence of antenatal fetal compromise.\n- Factors such as fetal hyperextended neck, high or low estimated fetal weight, footling presentation, and evidence of fetal compromise may require a caesarean section.\n- Maternal factors such as previous LSCS, raised BMI, maternal age >40 years, and other obstetric complications may also require a caesarean section.\nUptodate - 2025 - Preexisting and gestational diabetes - Intrapartum and postpartum glucose management.txt: In pregnancies complicated by diabetes, maintaining maternal euglycemia during labor is crucial to reduce adverse outcomes. Glycemic targets should be 70-125 mg/dL, individualized based on diabetes type. Maternal hyperglycemia during labor can lead to fetal hypoxemia and neonatal hypoglycemia. Insulin pumps can be used during labor, with protocols for intravenous insulin available. Postpartum insulin dosing is typically 30-35% of antenatal doses, adjusted based on glucose levels. Breastfeeding may lower insulin requirements. Metformin is recommended for type 2 diabetes postpartum and is compatible with breastfeeding. Close glucose monitoring postpartum is essential. Gestational diabetes may not need medication postpartum. Follow-up testing for diabetes postpartum is advised. Subcutaneous correctional insulin is often sufficient for managing gestational diabetes during labor, with insulin infusion an option if needed.\nGTG 2015 - Blood transfusion in Obstetrics.txt: The clinical guideline on Blood Transfusion in Obstetrics provides recommendations for reducing the risk of transfusion in pregnant women. It includes guidelines for optimizing hemoglobin levels, diagnosing anemia, and managing obstetric hemorrhage with blood components. Strategies to minimize the use of banked blood, such as preoperative autologous blood deposit and intraoperative cell salvage, are discussed. The guideline emphasizes obtaining consent for blood transfusion, regular monitoring of blood group and antibody status, and using appropriate blood products during pregnancy and the postpartum period. The importance of managing obstetric hemorrhage with mechanical strategies and close monitoring of clotting tests is highlighted.\nESHRE Guideline - 2022 - Endometriosis.txt: Endometriosis, a chronic inflammatory condition in women of reproductive age, presents with pain and infertility. Diagnosis involves imaging and laparoscopy. Management includes hormone therapy and surgery, guided by symptoms and fertility desires. Infertility treatments like IUI and ART can be considered. Hormone therapy post-surgery aids in pain management. Avoid unnecessary treatments in asymptomatic cases. Monitoring involves follow-up and psychological support. Risks include cancer and adverse pregnancy outcomes. Early diagnosis and appropriate treatment improve outcomes. Surgical and medical interventions are essential, with shared decision-making. Adjunct therapies like acupuncture may be considered. Ovarian suppression is ineffective for fertility. Hormone therapy prevents recurrence. Aromatase inhibitors may benefit postmenopausal women. Monitoring parameters include symptom improvement and fertility outcomes. Tibolone is a safe alternative for hormone therapy in menopause. Diagnosis and management of abdominal and thoracic endometriosis differ. Genetic testing is for research. Endometriosis does not significantly increase cancer risk. Monitoring for ovarian malignancy may not be beneficial. Bilateral salpingo-oophorectomy is not recommended without additional risk factors. Shared decision-making is crucial for pain management. Vigilance is needed during pregnancy for complications.\nUHSussex - MP049 - Assisted Vaginal Birth.txt: Summary:\n\nAssisted Vaginal Birth (RSCH PRH only) MP049 is a protocol for managing assisted instrumental vaginal births with the goal of mimicking spontaneous birth while minimizing morbidity. Key principles include professional judgment alongside protocol adherence. Indications and contraindications for operative vaginal birth are outlined, with a focus on reducing the need for such interventions. Risks of Ventouse and forceps deliveries are compared, and clear communication is emphasized for preparation. Informed consent, analgesia options, bladder care, hygiene, neonatal resuscitation, and perineal care protocols are detailed. Post-delivery documentation requirements and debriefing recommendations are provided. Monitoring parameters include timing and volume of first void, risk of urinary retention, and strategies for reducing urinary incontinence. Professional training in neonatal resuscitation and adherence to aseptic techniques are essential. Specific documentation requirements post-delivery and debriefing opportunities are emphasized for comprehensive care.\nESHRE GUIDELINE ENDOMETRIOSI 2022.txt: **Summary:**\n\n**Clinical Conditions and Management:**\n- Diagnosis of endometriosis involves symptoms like dysmenorrhea and infertility, with laparoscopy as the gold standard.\n- Treatment options include NSAIDs, hormone therapies, and surgical excision preferred over ablation for pain relief.\n- Monitoring parameters focus on pain relief and recurrence post-treatment.\n\n**Diagnostic Criteria and Thresholds:**\n- Recurrence rates vary post-surgery, and nerve-sparing laparoscopy can reduce urinary retention risk.\n\n**Medical Interventions and Timing:**\n- Postoperative hormone therapy may be considered for pain management.\n\n**Monitoring Parameters:**\n- Quality of life and fertility outcomes guide surgical management decisions.\n- The Endometriosis Fertility Index (EFI) aids in reproductive options post-surgery.\n\n**Contraindications and Risk Factors:**\n- Complications in bowel endometriosis surgery, especially rectal surgery, are significant.\n- Recurrence rates post-surgery are procedure-dependent.\n\n**Quantitative Values and Cutoffs:**\n- Surgical considerations for infertility vary by endometriosis stage.\n- Limited benefit shown for certain medications in improving pregnancy rates.\n\n**Conclusion:**\n- Individualized treatment plans based on shared decision-making are essential.\n- Further research is needed on non-medical management strategies and ART outcomes in endometriosis-associated infertility.\nNICE Guidance - 2024 - Endometriosis.txt: The NICE guideline on endometriosis diagnosis and management provides recommendations for healthcare professionals to effectively care for patients with this condition. It emphasizes individualized care based on symptoms, preferences, and priorities rather than solely on the stage of endometriosis. The guideline covers various aspects, including organization of care, information and support, diagnosis, pain management, surgical options, and fertility considerations. Additionally, it highlights the need for further research on alternative treatment options, the effectiveness of laparoscopic treatment for peritoneal endometriosis, lifestyle interventions, information and support interventions, and hormonal treatments' impact on fertility outcomes.\nClinical Consensus No. 455 Fetal Sex Determination and Disclosure.txt: Clinical Consensus No. 455 emphasizes the importance of fetal sex determination in obstetric ultrasound examinations and the respect for parental wishes regarding disclosure. Health care providers should make efforts to determine fetal sex during ultrasound exams and include a visible alert in reports if this information is present. The guideline highlights the significance of prenatal diagnosis of fetal genital anomalies and stresses the need for re-examination or referral if fetal sex cannot be determined. Ultimately, the guideline aims to ensure that fetal sex information is accurately communicated to patients and that their preferences are respected throughout the process.\nGTG 2016 - Epilepsy in Pregnancy.txt: The clinical guideline on epilepsy in pregnancy emphasizes the importance of proper diagnosis and management of epilepsy during pregnancy. It stresses the need for specialized care from a neurologist, assessment of risks to both mother and baby, and individualized treatment plans based on fetal risk and seizure control. The guideline also addresses the impact of antiepileptic drugs on pregnancy outcomes, the importance of folic acid intake, and the need for regular antenatal care with an epilepsy care team. Additionally, it provides recommendations for managing seizures during labor, monitoring AED levels, and postnatal care to ensure the well-being of both the mother and baby. Effective contraception is highlighted as crucial for stabilizing the condition and optimizing outcomes for women with epilepsy. Healthcare providers are encouraged to provide evidence-based information and support to empower women with epilepsy to make informed choices regarding their pregnancy and epilepsy management.\nGTG 2010 - Malaria in Pregnancy - Prevention.txt: Guideline for preventing malaria in pregnancy for UK residents visiting endemic areas emphasizes the risks, complications, and prevention strategies. Pregnant women are at higher risk of malaria complications, including maternal mortality and pregnancy loss. Recommendations include postponing travel if possible, using chemoprophylaxis like mefloquine in certain areas, and seeking prompt diagnosis and treatment. Standby treatment instructions should be given for suspected malaria, with quinine and clindamycin recommended for pregnant women. Individual patient needs should be considered when following these guidelines.\nGTG 2012 - Initial Mx of Chronic Pelvic Pain.txt: This clinical guideline focuses on the initial management of chronic pelvic pain in women. It emphasizes the importance of a thorough assessment to identify contributing factors and develop a comprehensive management plan. The guideline highlights the need for a partnership between the clinician and the woman to establish functional goals and monitor progress. Diagnostic criteria for conditions like IBS are discussed, along with the importance of considering non-gynecological components of pain. Various therapeutic options, including hormonal treatments and physical therapy, are recommended. The guideline also addresses the role of psychological factors and past trauma in chronic pelvic pain. Referral to specialists and appropriate investigations are suggested for cases where pain is not adequately controlled.\nUptodate - 2025 - Uterine fibroids (leiomyomas) Treatment overview - UpToDate.txt: Uterine fibroids are common in reproductive-age females and can cause symptoms like abnormal uterine bleeding, pressure, fertility issues, and pain. Treatment options include expectant management, hysteroscopic fibroid resection, medical therapy, GnRH agonists, uterine artery embolization, and various surgical options based on symptom severity and patient preference. Different medications like elagolix, relugolix, and linzagolix have shown efficacy in reducing menstrual bleeding. Laparoscopic myomectomy is preferred over open abdominal myomectomy due to less blood loss and lower complication rates. Patients desiring fertility can consider myomectomy or hysteroscopic myomectomy. UAE, hysterectomy, and GnRH analogs are options for patients not desiring future fertility or with bulk/pain symptoms.\nBJOG - 2016 -  - Management of Bladder Pain Syndrome.txt: Bladder Pain Syndrome (BPS) Management:\n- Initial assessment: thorough history, physical exam, bladder diary, and UTI testing\n- Diagnostic criteria: validated symptom scores, exclusion of other conditions\n- Management: dietary modifications, stress management, analgesia, intravesical treatments if needed\n- Monitoring: symptom scores, response to treatment\n- Contraindications: avoid certain medications and procedures in pregnancy\n- Quantitative values: symptom scores, medication dosages\n\nPelvic Pain Investigation:\n- Assessment: history of abuse, physical exam ruling out specific conditions\n- Diagnostic criteria: exclusion of other causes, baseline investigations\n- Management: conservative treatments, pharmacological options, multimodal therapy\n- Monitoring: response to treatment, multidisciplinary input\n- Contraindications: avoid specific medications and procedures\n- Quantitative values: symptom scores, medication dosages\n\nPregnancy and BPS:\n- Treatment options: safe medications like oral amitriptyline, intravesical heparin\n- Monitoring: symptom changes during pregnancy, genetic predisposition\n- Contraindications: avoid DMSO, consider safety of medications during pregnancy\n- Quantitative values: medication dosages, symptom severity assessments\n\nReferences:\n- Shorter B, Lesser M, Moldwin RM, Kushner L. J Urol 2007;178:145–52\n- Cervigni M, Natale F. Int J Urol 2014;21 Suppl 1:85–8\n- Foster HE Jr, Hanno PM, et al. J Urol 2010;183:1853–8\n- van Ophoven A, Pokupic S, et al. J Urol 2004;172:533–6\n- Nickel JC, Moldwin R, et al. BJU Int 2009;103:910–8\n\nClinical guidelines provide standardized recommendations for BPS management, emphasizing individual patient needs and resource availability. Evidence-based grading guides decision-making, highlighting areas for further research.\nUptodate - Approach to the patient with pregnancy of unknown location.txt: Diagnosis and Presentation:\n- Pregnancy of unknown location (PUL) is diagnosed when a patient with a positive pregnancy test has a transvaginal ultrasound showing neither an intrauterine pregnancy (IUP) nor an ectopic pregnancy.\n- Patients with PUL may be asymptomatic or present with symptoms of early pregnancy or ectopic pregnancy.\n- Differential diagnosis includes early IUP, ectopic pregnancy, molar pregnancy, and rare entities.\n\nTreatment and Management:\n- Initial evaluation involves history, physical examination, and transvaginal ultrasound.\n- Further diagnostic workup is based on ultrasound findings.\n- Serial serum human chorionic gonadotropin (hCG) measurements and transvaginal ultrasound assessments are done for selected patients.\n- Management depends on hemodynamic stability and pregnancy desires. Hemodynamically unstable patients require immediate surgical intervention, while stable patients may undergo expectant management with regular hCG and ultrasound assessments.\n\nMonitoring Requirements:\n- Monitor serial serum hCG levels.\n- Monitor transvaginal ultrasound assessments.\n- Monitoring frequency should be based on clinical judgment.\n\nContraindications and Cautions:\n- Hemodynamically unstable patients are contraindicated for expectant management.\n- Uncommon or rare etiologies such as malignancy, pituitary hCG production, and heterophilic antibodies are cautionary factors.\n- Patients with desired pregnancies require special considerations in management.\nGTG 2010 - Malaria in Pregnancy - Treatment.txt: Guideline emphasizes prompt diagnosis and treatment of malaria in pregnancy to prevent mortality. Symptoms include flu-like illness. Non-falciparum malaria is treated with chloroquine; severe falciparum cases require hospitalization and IV artesunate or quinine. Regular monitoring is crucial. IV artesunate is recommended for severe cases, seek expert consultation if needed. Clindamycin is not recommended in pregnancy. WHO suggests artemisinin-based therapy in later trimesters. Chloroquine and sulfadoxine-pyrimethamine are not recommended due to resistance. Radical cure with primaquine is not advised in pregnancy. Plasmodium falciparum can persist in the placenta post-treatment, necessitating careful monitoring.\nGTG 2015 - FGM.txt: The clinical guideline on Female Genital Mutilation (FGM) emphasizes the importance of healthcare professionals being aware of the complications and legal aspects of FGM. It highlights the need for mandatory reporting of FGM in girls under 18, clear referral pathways, and training for gynaecologists and midwives. De-infibulation should be offered before pregnancy, and postnatal care should include follow-up if not performed during delivery. The guideline also addresses the importance of a safe and private environment, psychological assessment, and vigilance for clinical signs of recent FGM. Data collection on FGM in the UK is essential for tracking care for affected women.\nBJOG - 2022 - Girling - Intrahepatic cholestasis of pregnancy.txt: Recommendations for intrahepatic cholestasis of pregnancy (ICP) management include considering ICP in pregnant women with itching and bile acid concentration of 19 micromol/L or higher, discussing severe cases with a hepatologist, and confirming postnatal resolution. Stillbirth risk increases with peak bile acid concentrations, especially in twin pregnancies. Ultrasound and CTG do not predict or prevent stillbirth in ICP. Ursodeoxycholic acid is not routinely recommended for adverse perinatal outcomes in ICP. Continuous fetal monitoring is advised for women with peak bile acids of 100 micromol/L or more. Follow-up postpartum is essential to confirm resolution. Future research should focus on prognostic tools, testing for gestational diabetes, and effective treatments for itching and adverse perinatal outcomes in ICP.\nGuideline No. 451 Asymptomatic Endometrial Thickening in Postmenopausal Women.txt: The SOGC Clinical Practice Guideline No. 451 addresses the management of asymptomatic endometrial thickening in postmenopausal women. It emphasizes that routine pelvic ultrasound is not recommended for screening for endometrial cancer and that most patients with endometrial cancer present with postmenopausal bleeding. The guideline provides recommendations for further investigations based on individual risk factors and ultrasound findings, with endometrial thickness <11 mm associated with a low risk of malignancy. It also discusses the impact of hormone therapy on endometrial health and provides recommendations for preoperative ripening of the cervix before hysteroscopy. The guideline highlights the importance of individualized care and appropriate management based on specific patient factors.\nNICE - 2021 - Antenatal Care.txt: The NICE antenatal care guideline emphasizes the importance of involving partners in care decisions, providing comprehensive care for pregnant women, and addressing common problems during pregnancy. Recommendations include assessing risk factors, discussing fetal movements, offering support for women with increased risk factors, and providing information on various aspects of antenatal care. The guideline also covers interventions for nausea and vomiting, heartburn, and pelvic girdle pain. It highlights the importance of addressing inequalities in care, discussing sleep positions to reduce stillbirth risk, and providing peer support services. The guideline aims to improve antenatal care practices without major changes in practice.\nBJOG - 2020 -  Management of Gestational Trophoblastic Disease.txt: The clinical guideline on the management of Gestational Trophoblastic Disease emphasizes the importance of recognizing the symptoms and signs of molar pregnancies, such as irregular vaginal bleeding and positive pregnancy tests. The definitive diagnosis is made through histological examination, and suction curettage is the preferred method for removal. Women with persistently elevated hCG levels should be referred to a GTD center, and those with suspected GTN should be investigated promptly. Follow-up care is crucial, and women are advised to wait before conceiving again. Support and resources are available for those affected by GTD. Research is ongoing to improve outcomes and management strategies.\nBJOG - 2019 - Thomson - Care of Women Presenting with Suspected Preterm Prelabour Rupture of Membranes from 24 0 Weeks of.txt: The clinical guideline provides key recommendations for the diagnosis and management of preterm premature rupture of membranes (PPROM). It emphasizes the importance of accurate diagnosis through maternal history and speculum examination, as well as the use of IGFBP-1 or PAMG-1 tests when necessary. Antibiotics, corticosteroids, and magnesium sulfate are recommended for appropriate cases, with neonatologist involvement and expectant management until 37 weeks gestation. The guideline also highlights the need for emotional support and further research in PPROM management. Gynaecologists are encouraged to refer to relevant resources and support groups for additional information. The guideline was developed by a team of healthcare professionals and will be reviewed periodically for updates.\nGTG 2008 - Prevention of Entry-Related Laparoscopic Injuries.txt: RCOG Green-top Guideline No. 49 focuses on preventing entry-related gynaecological laparoscopic injuries, aiming to reduce serious complications associated with laparoscopic surgery. Surgeons are advised to be trained in safe techniques, insert the primary trocar at 90 degrees to the skin, and maintain intra-abdominal pressure before insertion. Alternative entry techniques and sites, such as Palmer's point, are recommended in certain cases. Special care is needed for entry in specific patient populations. Documentation of counseling and reporting adverse events are essential. The guideline emphasizes the importance of appropriate training, supervision, and experience in laparoscopic surgery, with recommendations based on expert opinions and clinical experiences.\nGuideline No. 452 Diagnosis and Management of Intrahepatic Cholestasis of Pregnancy.txt: Intrahepatic cholestasis of pregnancy is a liver condition that can have serious consequences for both the mother and the fetus. It is characterized by itching and elevated bile acids, and can lead to preterm birth, neonatal respiratory distress, and stillbirth. Treatment involves medication to alleviate symptoms and early delivery based on bile acid levels. Recurrence in future pregnancies is common, and monitoring and delivery timing should be based on bile acid levels. Close monitoring during labor is recommended, and resolution of symptoms should be confirmed postpartum. Patients and family members are at higher risk for ICP in future pregnancies, and contraceptive options should be discussed.\nNICE Guidance - 2023 - Ectopic.txt: The clinical guideline on Ectopic pregnancy and miscarriage: diagnosis and initial management focuses on improving the diagnosis and management of ectopic pregnancy and miscarriage in women with early pregnancy complications. Recommendations include providing support and information with dignity, offering early pregnancy assessment services 7 days a week, and recognizing symptoms of ectopic pregnancy for prompt referral. The guideline emphasizes the importance of offering systemic methotrexate or surgery for tubal ectopic pregnancy based on specific criteria. Further research is needed to assess the psychological impact of different interventions on women's emotional recovery. Standardizing practices based on evidence will improve diagnosis and reduce risks, ultimately improving the quality of care for women experiencing early pregnancy loss.\nUptodate - Pregnancy Loss Ultrasound Diagnosis.txt: Diagnosis and Presentation:\n- Pregnancy loss, or miscarriage, is defined as a nonviable intrauterine pregnancy up to 20 weeks of gestation.\n- Early pregnancy loss occurs in the first trimester and is the most common type.\n- Diagnosis is confirmed with transvaginal ultrasound evaluation.\n- Ultrasound criteria for diagnosis include:\n  - Gestational sac 25 mm in mean diameter without a yolk sac or embryo.\n  - Embryo with a CRL 27 mm without cardiac activity.\n  - Absence of an embryo with a heartbeat in 22 weeks from a prior ultrasound showing a gestational sac without a yolk sac.\n  - After a pelvic ultrasound showed a gestational sac with a yolk sac, absence of an embryo with a heartbeat in 21 days.\n  - Initial criteria for nonviable early pregnancy include CRL of 5 mm without cardiac activity and an empty gestational sac measuring 16 mm in mean diameter.\n- Challenging scenarios in early pregnancy assessment include gestational duration discrepancy, multiple gestations, and pregnancy of unknown location.\n- Additional ultrasound findings suggestive of non-viable pregnancy include expanded or empty amnion.\n- Findings suggestive of poor outcome include irregularly shaped gestational sac, moderate or large subchorionic hematoma, and chorionic bump.\n- Findings consistent with live pregnancy include a gestational sac with a yolk sac only and a normal pregnancy with amnion.\n\nTreatment and Management:\n- Guidelines recommend transvaginal ultrasonographic diagnosis of pregnancy failure in a woman with an intrauterine pregnancy of uncertain viability.\n- Diagnosis of early pregnancy loss is made using transvaginal ultrasound.\n- Various ultrasound criteria are used to diagnose pregnancy loss.\n\nMonitoring Requirements:\n- Monitoring of gestational sac diameter and cardiac activity may be needed.\n- Frequency of monitoring may vary based on clinical context.\n\nContraindications and Cautions:\n- No specific contraindications mentioned.\n- Risk factors include varying levels of stringency in ultrasound techniques and the consideration of false-positive rates in diagnosis.\nJoint RCOG and BSGE Guideline- Laparoscopy in Pregnancy.txt: The clinical guideline focuses on the laparoscopic management of non-obstetric, abdominal conditions in pregnancy, such as acute appendicitis, gallbladder disease, and benign adnexal tumors. It highlights the importance of experienced laparoscopists to ensure maternal and fetal safety, as studies have shown that laparoscopy is safe with no increased risk of adverse outcomes compared to open surgery. Factors such as expertise, infrastructure, gestation, and patient preference should be considered when choosing the type of surgery. Maternal and fetal outcomes are generally good for laparoscopic surgery in pregnancy, with skilled surgeons having better outcomes. Urgent surgery should not be delayed, and both laparoscopic and open surgery are acceptable options.\nGTG 2011 - Pregnancy and Breast Cancer.txt: The clinical guideline provides guidance for health professionals caring for women of childbearing age with breast cancer. It emphasizes the importance of a multidisciplinary team approach for optimal management. Women diagnosed during pregnancy have a similar prognosis to non-pregnant women, but treatment should consider tumor characteristics and pregnancy stage. Non-hormonal contraception is recommended after treatment, and women planning pregnancy should consult with their healthcare providers. Pregnancy after breast cancer does not adversely affect long-term survival, and women can be reassured about the risk of malformations in children conceived after treatment. Fertility preservation options should be discussed before treatment, and assisted reproduction may be considered if needed.\nBJOG - 2021 - Navaratnam - Amniocentesis and chorionic villus sampling.txt: Amniocentesis and chorionic villus sampling are prenatal diagnostic tests with a low risk of miscarriage. Amniocentesis should be performed after 15 weeks of gestation, while CVS should be done after 10 weeks. Multiple pregnancies slightly increase the risk of miscarriage. Screening for blood-borne viruses is important before invasive tests. Proper training and good practice are crucial to reduce risks. Severe maternal sepsis is rare, and infection can occur from various sources. Third-trimester amniocentesis may be offered for specific fetal conditions. Antiretroviral treatment should be optimized for HIV-positive women. The risk of mother-to-child transmission of HBV increases with higher viral loads. There is no evidence of transmission risk for HCV following amniocentesis.\nBJOG - 2017 -  Prevention of Early‐onset Neonatal Group B Streptococcal Disease.txt: The clinical guideline for the Prevention of Early-onset Neonatal Group B Streptococcal Disease emphasizes the importance of clinical risk factors for GBS disease and provides recommendations for intrapartum antibiotic prophylaxis (IAP) for known carriers. While routine testing for GBS in pregnancy is not recommended due to potential inaccuracies and risks, IAP should be offered to women with previous GBS infection or bacteriuria. Immediate IAP is recommended for known carriers at term, and broad-spectrum antibiotics should be considered for pyrexial women in labor. Babies showing signs of EOGBS disease should be promptly treated, and breastfeeding is encouraged regardless of GBS status. Close monitoring is advised for babies of mothers who decline IAP. The guideline also addresses various studies related to GBS colonization, antibiotic treatment, and maternal and infant outcomes, providing a comprehensive overview of evidence-based recommendations. It is important to consider individual patient data and local protocols when implementing these guidelines.\nBHIVA - 2020 - HIV Guideline.txt: Diagnosis and Presentation:\n- Antiretroviral therapy (ART) initiation during pregnancy and lifelong treatment for pregnant women living with HIV\n- Assessment of antenatal and postnatal depression\n- Sexual health screening for newly diagnosed pregnant women with HIV\n- Continuation of effective combination antiretroviral therapy (cART) for women conceiving on cART\n- Recommendation of Tenofovir DF or abacavir with emtricitabine or lamivudine as nucleoside backbone\n- Deferral of invasive prenatal diagnostic testing until HIV status is known\n- Mode of delivery based on maternal viral load\n\nTreatment and Management:\n- Multidisciplinary antenatal HIV care\n- Peer support for pregnant women living with HIV\n- HIV resistance testing before treatment initiation\n- Regular CD4 cell counts and HIV viral load tests for women conceiving on cART\n- Initiation of treatment for pregnant women with baseline viral load >100,000 HIV RNA copies/mL by the start of the second trimester\n- Integrase inhibitor-based regimens for certain patients\n- Discussion of dolutegravir use in pregnancy considering risks of neural tube defects\n- Monitoring of liver function tests and interventions for unsuppressed viral load\n- Postpartum care including cART continuation, mental health evaluation, and contraception discussion\n\nMonitoring Requirements:\n- Monitoring of CD4 cell counts throughout pregnancy\n- Regular HIV viral load tests during pregnancy\n- Monitoring of liver function tests\n- Monitoring of infant HIV status with molecular diagnostics and antibody testing\n\nContraindications and Cautions:\n- Deferral of invasive prenatal diagnostic tests until viral load is <50 HIV RNA copies/mL\n- Immediate testing required if viral load is ≥400 copies/mL, with cART and nevirapine administration\n- Vaginal delivery supported for viral load <50 copies/mL, cesarean section recommended for viral load ≥400 copies/mL\n- Postpartum zidovudine infusion recommended for viral load >1000 copies/mL\n- Breastfeeding supported for virologically suppressed women, formula feeding recommended otherwise\n\nDiagnosis and Presentation:\n- Increased risk of preterm delivery with protease inhibitors vs nucleoside reverse transcriptase inhibitor-based HAART during pregnancy\n- No difference in risk of preterm birth between lopinavir/ritonavir vs efavirenz-based ART\n- Unique management considerations for HIV, chronic HBV infection, and pregnancy\n- Routine monitoring of liver function tests throughout pregnancy and postpartum\n- Management of women with both HCV and HIV during pregnancy\n- Fetal ultrasound imaging recommended regardless of maternal HIV status\n- Mode of delivery based on plasma viral load results at 36 weeks\n\nTreatment and Management:\n- Referral to specialist for comprehensive care for HIV, chronic HBV infection, and pregnancy\n- Tenofovir DF, emtricitabine, and lamivudine as backbone for HIV/HBV co-infection treatment\n- Consideration of tenofovir alafenamide after first trimester\n- Maternal cART with prompt neonatal immunoprophylaxis for preventing vertical transmission of HBV\n- Immediate neonatal immunisation within 24 hours of delivery\n- Zidovudine monotherapy or combination post-exposure prophylaxis (PEP) for infants based on risk level\n- Co-trimoxazole prophylaxis for HIV-infected infants\n- Breastfeeding advice for women with HIV\n\nMonitoring Requirements:\n- Regular monitoring of liver function tests throughout pregnancy and postpartum\n- Regular monitoring of plasma viral load for risk level determination and treatment approach\n- Monthly clinic visits for HIV RNA viral load testing during and after breastfeeding\n- Disclosure of HIV status to partner/family and healthcare provider\n- Molecular diagnostics for HIV infection in infants\n\nContraindications and Cautions:\n- Relative contraindication of liver biopsy and hepatic elastometry during pregnancy\n- Contraindication of ribavirin in pregnancy and avoidance in male partners of pregnant women\n- Immediate discontinuation of ribavirin if pregnancy occurs during treatment\n- Limited duration of PEP for infants, not exceeding 2 weeks for very low-risk or 4 weeks for low-risk infants even if breastfed\nBJOG - 2017 -  Management of Inherited Bleeding Disorders in Pregnancy.txt: Management of inherited bleeding disorders in pregnancy involves monitoring and maintaining factor levels, offering prenatal diagnosis for severe hemophilia carriers, utilizing treatments like tranexamic acid and factor concentrates, and providing antenatal care by a multidisciplinary team. Postpartum management includes maintaining factor levels and monitoring for bleeding. Neonatal management involves diagnostic testing, administering vitamin K, and considering prophylaxis in severe cases. Women with VWD have an increased bleeding risk during pregnancy, and intrapartum management should focus on maintaining VWF activity levels. Factor XI deficiency poses risks of PPH and can be managed with tranexamic acid, factor XI concentrate, and FFP. Tailoring treatment for rare bleeding disorders involves adjusting interventions based on individual bleeding patterns. Genetic testing for at-risk fetuses can be done through CVS or amniocentesis, and PGD is an option for couples at risk of heritable disorders. Close monitoring and individualized care are essential during pregnancy and delivery for women with inherited bleeding disorders.\nBJOG - 2018 - Denison - Care of Women with Obesity in Pregnancy.txt: The clinical guideline on the care of women with obesity in pregnancy, released in November 2018, emphasizes the importance of pre-pregnancy care, antenatal care, information giving during pregnancy, risk assessment, and special considerations for screening, diagnosis, and management of maternal disease in women with obesity. Recommendations include providing information on risks associated with obesity, monitoring weight and height, screening for gestational diabetes, and offering mental health screening. The guideline also addresses fetal surveillance, planning for labor and birth, anesthetic and obstetric outcomes, and postnatal care. It highlights the need for multidisciplinary care and tailored support for women with obesity before, during, and after pregnancy.\nGTG 2015 - Birth After Previous CS.txt: This clinical guideline on Birth After Previous Caesarean Birth provides recommendations for antenatal care, counselling, and decision-making for women with prior cesarean deliveries. It discusses the suitability of planned vaginal birth after cesarean (VBAC) for most women with a single prior cesarean, contraindications to VBAC, and factors influencing VBAC success rates. The guideline emphasizes the importance of continuous monitoring during VBAC, the risks associated with induction or augmentation of labor, and the timing and perioperative care for elective repeat cesarean sections. It also highlights the need for personalized decision-making, patient counseling, and further research on predicting successful VBAC outcomes.\nNICE Guideline - 2021 - IOL.txt: The NICE guideline on inducing labor covers the circumstances, methods, assessment, monitoring, pain relief, and complications of labor induction to improve care for pregnant women. Recommendations include discussing birth preferences early, offering expectant management for uncomplicated pregnancies, and considering individual circumstances and risks. The guideline addresses specific scenarios such as preterm prelabor rupture of membranes, breech position, and fetal growth restriction. Monitoring fetal wellbeing and managing complications like hyperstimulation are crucial during induction. Research recommendations focus on optimal timing and management of preterm rupture of membranes. The guideline aims to provide information and support for informed decision-making in labor induction.\nBJOG - 2022 - Shennan - Cervical Cerclage.txt: The clinical guideline on Cervical Cerclage provides recommendations for the insertion of cerclage in women at risk of preterm birth and second trimester fetal loss. It outlines key recommendations for history-indicated and ultrasound-indicated cerclage, as well as emergency cerclage in specific situations. The guideline emphasizes the importance of individualized care and informed decision-making, highlighting potential complications and contraindications to cerclage insertion. It also discusses the types of cerclage techniques, suture materials, and adjuvant management strategies. The guideline calls for further research in certain areas to improve understanding and outcomes related to cerclage procedures.\nBJOG - 2020 - Murphy - Assisted Vaginal Birth.txt: The clinical guideline on Assisted Vaginal Birth emphasizes the importance of preparation, assessment, and expertise in performing assisted vaginal births. It recommends continuous support during labor, different positions during the second stage of labor, and delayed pushing in certain situations to reduce the need for assisted birth. The guideline outlines when to recommend or contraindicate assisted vaginal birth, conditions for safe practice, and the importance of obtaining consent. It also addresses aftercare, documentation, and the importance of training and supervision in performing assisted births. The guideline highlights the risks, benefits, and techniques associated with vacuum and forceps deliveries, as well as the importance of informed decision-making and psychological support for women undergoing assisted births.\nGTG 2015 - Chickenpox in Pregnancy.txt: This clinical guideline on Chickenpox in Pregnancy focuses on prevention and management strategies for pregnant women. It recommends varicella vaccination for non-immune women, avoiding contact with chickenpox, and testing for VZV immunity if exposed. Treatment with VZIG and aciclovir is advised for non-immune pregnant women with chickenpox. Risks to the fetus and newborn are discussed, with individualized delivery plans for pregnant women with chickenpox. Screening for VZV immunity is not routinely recommended in the UK. Early notification to healthcare providers, isolation, and careful monitoring are essential for pregnant women with chickenpox. Prophylaxis with VZIG is crucial for newborns exposed to chickenpox. Further research and support resources are available for managing chickenpox in pregnancy.\nBJOG - 2017 -  External Cephalic Version and Reducing the Incidence of Term Breech Presentation.txt: External Cephalic Version (ECV) is a procedure to turn a breech baby to a head-down position, reducing the chances of a caesarean section. It should be offered at term from 37 weeks of gestation, with tocolysis potentially improving success rates. Regional analgesia may be considered for pain relief during the procedure. ECV should only be performed by trained practitioners, and women should be informed of the risks and benefits. Further research is needed to improve ECV outcomes and methods to increase uptake and success rates. ECV has a low complication rate and does not increase the risk of intrauterine death.\nUptodate - 2025 - Prelabor rupture of membranes at term.txt: Prelabor rupture of membranes (PROM) at term involves the early rupture of fetal membranes before contractions. Management decisions include inducing labor to reduce infection risk or waiting for spontaneous labor. Oxytocin induction is preferred for uncomplicated cases, while expectant management is an option for low-risk patients. Hospitalization is recommended to monitor for complications. Antibiotic prophylaxis is used selectively. Induction with oxytocin reduces neonatal infections. GBS status influences antibiotic use. Expectant management includes infection and fetal monitoring. Monitoring and decisions should be based on individual risk assessment.\nBJOG - 2022 - Stock - Antenatal corticosteroids to reduce neonatal morbidity and mortality.txt: Antenatal corticosteroids are recommended for women at risk of preterm birth to reduce perinatal and neonatal death, respiratory distress syndrome, and other adverse outcomes. They should be offered to women between 24+0 and 34+6 weeks' gestation, including those with twins and triplets. Corticosteroids should not be delayed if birth is necessary for the health of the woman or baby. Careful consideration is needed for the use of corticosteroids in late preterm births, multiple pregnancies, diabetes, and other special populations. Research is ongoing to determine the safety and effectiveness of corticosteroids in various conditions, with recommendations for future studies provided.\nUHSussex - MP059 - Baby Abduction Policy.txt: Diagnosis and Presentation:\n- Suspected or actual baby abduction in the hospital setting\n- Staff in maternity, portering, security, and switchboard departments involved\n- Immediate actions: informing security, contacting the police, coordinating the response\n\nTreatment and Management:\n- Move parents to a private area\n- Check identification bands\n- Reassure mothers\n- Cooperate with the police\n- Manage media inquiries through Trust's Communications Manager and senior management\n\nMonitoring Requirements:\n- Audit the guidance after each reported abduction incident\n\nContraindications and Cautions:\n- Failure to follow the protocol in case of suspected or actual baby abduction\n- Non-adherence to visiting hours and restrictions\n\nRisk Factors:\n- Lack of staff adherence to guidance and protocols\n- Inadequate training on baby abduction risks and actions\nUHS Anaemia in pregancy UHS-CG-0008-2023 (3).txt: This document provides evidence-based guidance for managing anaemia during pregnancy and the postnatal period. It covers causes, consequences, screening, and treatment options for iron deficiency, including dietary advice, oral iron replacement, and intravenous iron therapy. Monitoring hemoglobin levels is crucial, and treatment should be tailored based on individual needs and responses. Special considerations are outlined for high-risk individuals and those with contraindications for certain treatments. Prioritizing iron infusion for pregnant individuals with low hemoglobin levels approaching term is recommended to reduce the risk of postpartum complications. Blood transfusion should be considered cautiously, with informed consent and documentation of discussions.\nBJOG - 2016 - Diagnosis and Management of Ectopic Pregnancy.txt: The clinical guideline for the Diagnosis and Management of Ectopic Pregnancy emphasizes the importance of transvaginal ultrasound for diagnosis, visualizing adnexal masses for tubal ectopic pregnancies, and using serum beta-human chorionic gonadotrophin levels for management planning. Specific criteria exist for diagnosing various types of ectopic pregnancies, with surgical, pharmacological, and conservative treatment options available. Long-term fertility prospects should be discussed with patients, and support and counseling should be offered during treatment. Providers should have appropriate training for ultrasound-guided needle techniques, and anti-D immunoglobulin should be offered to women with ectopic pregnancies. The guideline also addresses the management of different types of ectopic pregnancies and provides recommendations for future studies and auditable topics.\nNICE Guidance - 2010 - Hysterectomy for Endometrial Cancer.txt: Laparoscopic hysterectomy is a safe and effective option for endometrial cancer when proper clinical governance, consent, and audit arrangements are in place. Patient selection by a multidisciplinary gynecological oncology team is crucial. Advanced laparoscopic skills are necessary, and additional training is recommended. The procedure offers a less invasive approach with shorter recovery times compared to open surgery. Conversion to laparotomy rates may vary, but postoperative complications are generally lower with laparoscopic hysterectomy. More data on long-term outcomes are needed for future evaluations.\nJoint RCOG BSGE Guideline - Suspected Ovarian Masses in Premenopausal Women.txt: This guideline provides recommendations for the assessment and management of suspected ovarian masses in premenopausal women. It emphasizes the importance of early diagnosis and referral to a gynaecological oncologist for suspicious cases. Conservative management and laparoscopic techniques are recommended for benign masses, with specific guidelines for follow-up and surgical intervention based on the size and characteristics of the mass. Serum CA-125 levels and ultrasound findings are key factors in assessing the risk of malignancy, with additional risk assessment tools available. The guideline also addresses the role of laparoscopic surgery in managing ovarian masses, highlighting the importance of experienced surgeons and minimizing spillage of cyst contents to prevent potential malignancy.\nGTG 2011 - APH.txt: Antepartum haemorrhage (APH) is a significant complication of pregnancy, with placenta praevia and placental abruption being the main causes. It is associated with maternal and perinatal morbidity and mortality, and prompt clinical assessment and management are crucial. Triage, maternal stabilization, and investigations are important steps in the management of APH. Delivery may be necessary in cases of maternal or fetal compromise, with caesarean section typically used for placenta praevia. Postpartum hemorrhage should be anticipated, and appropriate blood products should be available for massive APH cases. Continuous fetal monitoring and neonatal assessment are essential for optimal outcomes. Future research should focus on interventions to prevent placental abruption and optimal timing of delivery in cases of unexplained APH.\nBMS - 2024 - Management of unscheduled bleeding on HRT.txt: A guideline for managing unscheduled bleeding on hormone replacement therapy (HRT) emphasizes assessing women for endometrial cancer risk factors, investigating bleeding patterns, and adjusting HRT to reduce episodes. Recommendations include assessing compliance, considering low-dose preparations, and offering alternative progestogens or non-hormonal options based on individual factors. Endometrial assessment and management options are provided, with recommendations for adjusting HRT based on ultrasound findings and endometrial histology. Referral for ultrasound is advised in certain cases, and surgical options like hysteroscopic myomectomy or endometrial ablation may be considered. The document highlights the importance of individualized care and efficient resource utilization in managing unscheduled bleeding on HRT.\nESHRE PIL - Endometriosis.txt: This booklet provides comprehensive information on endometriosis, a chronic disease affecting women. It covers symptoms, diagnosis, and treatment options such as medication, hormonal therapy, and surgery. It also addresses the impact of endometriosis on fertility and discusses options for enhancing fertility. The importance of communication with a doctor in developing a suitable treatment plan is emphasized. The booklet also includes information on various endometriosis organizations for additional support. It is important to note that the information provided is for general knowledge and should not replace medical advice.\nJoint RCOG BASHH Guideline - Genital Herpes in Pregnancy.txt: The clinical guideline for the Management of Genital Herpes in Pregnancy provides recommendations for healthcare professionals on the care of pregnant women with genital herpes simplex virus infection. It covers antenatal, intrapartum, and postnatal care, including the use of aciclovir for treatment and prevention of neonatal herpes transmission. The guideline recommends vaginal delivery for most cases, with caesarean section advised for women with third trimester acquisition of herpes. It also addresses the management of recurrent herpes and the importance of preventing postnatal transmission. Stakeholder involvement and a comprehensive literature search informed the development of this guideline to ensure evidence-based recommendations for the management of genital herpes in pregnancy.\nBJOG - 2024 - DeÂ Silva - Outpatient Hysteroscopy.txt: Recommendations for outpatient hysteroscopy include providing written information before the appointment, offering various analgesic options, avoiding routine conscious sedation, and using vaginoscopy as the standard technique. Mechanical hysteroscopic tissue removal systems are preferred, and saline should be instilled at low pressure for optimal visualization. Cervical preparation with prostaglandins can be considered in selected cases. Flexible hysteroscopes and smaller-diameter instruments are associated with less pain and better outcomes. Monitoring for adverse events and ensuring informed consent are crucial. Studies have evaluated pain management methods and cervical preparation efficacy in outpatient hysteroscopy. Different hysteroscope types and medications can impact patient experience and procedure success.",
    "filenames": [
      "GTG 2014 - Endometrial Hyperplasia.txt",
      "BJOG - 2017 -  Management of Breech Presentation.txt",
      "RCOG - Birth After Previous Caesarean Section - 2015.txt",
      "UHSussex - MP046 - Management of Breech and ECV.txt",
      "Uptodate - 2025 - Preexisting and gestational diabetes - Intrapartum and postpartum glucose management.txt",
      "GTG 2015 - Blood transfusion in Obstetrics.txt",
      "ESHRE Guideline - 2022 - Endometriosis.txt",
      "UHSussex - MP049 - Assisted Vaginal Birth.txt",
      "ESHRE GUIDELINE ENDOMETRIOSI 2022.txt",
      "NICE Guidance - 2024 - Endometriosis.txt",
      "Clinical Consensus No. 455 Fetal Sex Determination and Disclosure.txt",
      "GTG 2016 - Epilepsy in Pregnancy.txt",
      "GTG 2010 - Malaria in Pregnancy - Prevention.txt",
      "GTG 2012 - Initial Mx of Chronic Pelvic Pain.txt",
      "Uptodate - 2025 - Uterine fibroids (leiomyomas) Treatment overview - UpToDate.txt",
      "BJOG - 2016 -  - Management of Bladder Pain Syndrome.txt",
      "Uptodate - Approach to the patient with pregnancy of unknown location.txt",
      "GTG 2010 - Malaria in Pregnancy - Treatment.txt",
      "GTG 2015 - FGM.txt",
      "BJOG - 2022 - Girling - Intrahepatic cholestasis of pregnancy.txt",
      "Guideline No. 451 Asymptomatic Endometrial Thickening in Postmenopausal Women.txt",
      "NICE - 2021 - Antenatal Care.txt",
      "BJOG - 2020 -  Management of Gestational Trophoblastic Disease.txt",
      "BJOG - 2019 - Thomson - Care of Women Presenting with Suspected Preterm Prelabour Rupture of Membranes from 24 0 Weeks of.txt",
      "GTG 2008 - Prevention of Entry-Related Laparoscopic Injuries.txt",
      "Guideline No. 452 Diagnosis and Management of Intrahepatic Cholestasis of Pregnancy.txt",
      "NICE Guidance - 2023 - Ectopic.txt",
      "Uptodate - Pregnancy Loss Ultrasound Diagnosis.txt",
      "Joint RCOG and BSGE Guideline- Laparoscopy in Pregnancy.txt",
      "GTG 2011 - Pregnancy and Breast Cancer.txt",
      "BJOG - 2021 - Navaratnam - Amniocentesis and chorionic villus sampling.txt",
      "BJOG - 2017 -  Prevention of Early‐onset Neonatal Group B Streptococcal Disease.txt",
      "BHIVA - 2020 - HIV Guideline.txt",
      "BJOG - 2017 -  Management of Inherited Bleeding Disorders in Pregnancy.txt",
      "BJOG - 2018 - Denison - Care of Women with Obesity in Pregnancy.txt",
      "GTG 2015 - Birth After Previous CS.txt",
      "NICE Guideline - 2021 - IOL.txt",
      "BJOG - 2022 - Shennan - Cervical Cerclage.txt",
      "BJOG - 2020 - Murphy - Assisted Vaginal Birth.txt",
      "GTG 2015 - Chickenpox in Pregnancy.txt",
      "BJOG - 2017 -  External Cephalic Version and Reducing the Incidence of Term Breech Presentation.txt",
      "Uptodate - 2025 - Prelabor rupture of membranes at term.txt",
      "BJOG - 2022 - Stock - Antenatal corticosteroids to reduce neonatal morbidity and mortality.txt",
      "UHSussex - MP059 - Baby Abduction Policy.txt",
      "UHS Anaemia in pregancy UHS-CG-0008-2023 (3).txt",
      "BJOG - 2016 - Diagnosis and Management of Ectopic Pregnancy.txt",
      "NICE Guidance - 2010 - Hysterectomy for Endometrial Cancer.txt",
      "Joint RCOG BSGE Guideline - Suspected Ovarian Masses in Premenopausal Women.txt",
      "GTG 2011 - APH.txt",
      "BMS - 2024 - Management of unscheduled bleeding on HRT.txt",
      "ESHRE PIL - Endometriosis.txt",
      "Joint RCOG BASHH Guideline - Genital Herpes in Pregnancy.txt",
      "BJOG - 2024 - DeÂ Silva - Outpatient Hysteroscopy.txt"
    ],
    "summaries": [
      "The clinical guideline for the management of endometrial hyperplasia emphasizes the importance of identifying and monitoring risk factors, utilizing the WHO classification for diagnosis, and implementing appropriate surveillance methods such as endometrial sampling and hysteroscopy. Progestogens, particularly the levonorgestrel-releasing intrauterine system (LNG-IUS), are recommended for managing hyperplasia without atypia, with surgical options considered in certain cases. Total hysterectomy is advised for atypical hyperplasia, especially for women no longer requiring fertility. The guideline also addresses specific considerations for women on hormone replacement therapy, adjuvant breast cancer treatment, and tamoxifen therapy. Regular surveillance and follow-up biopsies are essential for monitoring disease regression and progression. Future research recommendations and auditable topics are highlighted, along with useful links and support groups for further information and support.",
      "The clinical guideline on the Management of Breech Presentation provides recommendations for the management of breech presentation at term. It suggests offering external cephalic version (ECV) to women with breech presentation unless contraindicated, and counseling on the risks and benefits of ECV and implications for mode of delivery. The guideline discusses the risks and benefits of planned vaginal breech delivery versus planned caesarean section, highlighting the reduction in perinatal mortality with caesarean section but also the risks associated with future pregnancies. Skilled intrapartum care and adherence to a management protocol are emphasized for safe vaginal breech delivery. Research recommendations and audit topics are also included.",
      "The clinical guideline on Birth After Previous Caesarean Birth recommends antenatal care, offering planned VBAC to most women with a single previous lower segment caesarean delivery. The success rate of VBAC is 72-75%, with previous vaginal delivery being a predictor of success. Induction or augmentation of labour increases the risk of uterine rupture. ERCS should be conducted after 39+0 weeks with antibiotics and thromboprophylaxis given. VBAC may not be suitable for pregnancies with certain complications. Consideration should be given to attempting VBAC in women with multiple future pregnancies. The guideline emphasizes the importance of individualized antenatal care and documented counseling by a member of the maternity team.",
      "Diagnosis and Presentation:\n- Breech presentation is defined as a fetus in longitudinal lie with the buttocks, legs, or feet in the lower uterine segment closest to the cervix.\n- Types of breech presentation include frank or extended breech, complete or flexed breech, footling breech, and kneeling breech.\n- Pregnant individuals with confirmed breech presentation should be offered external cephalic version (ECV) at 36-37 weeks of gestation.\n- Absolute contraindications for ECV include conditions like placenta previa, antepartum hemorrhage, severe preeclampsia, and abnormal fetal dopplers.\n- Risk factors for planned vaginal breech birth include hyperextended neck on ultrasound, high or low estimated fetal weight, footling presentation, and evidence of antenatal fetal compromise.\n\nTreatment and Management:\n- ECV should be performed by trained obstetricians and monitored for complications.\n- Pregnant individuals declining ECV or with persistent breech presentation should be informed of birth options such as planned caesarean section or vaginal breech birth.\n- Pregnant individuals opting for elective LSCS for breech presentation should be informed about timing and potential risks.\n- Pregnant individuals choosing vaginal breech birth should have antenatal assessment and be referred to appropriate clinics for care.\n- Multidisciplinary team approach is recommended for planned vaginal breech birth.\n- Continuous CTG monitoring is recommended in established labor.\n- Maternal observations should be performed regularly throughout labor.\n- Intravenous cannula is recommended on admission for individuals with anticipated difficulty with IV access.\n- Upright position and mobility in labor should be encouraged.\n- Full range of pain relief options should be available.\n- Birthing individuals should feel calm, in control, and supported during labor and birth.\n\nMonitoring Requirements:\n- Continuous CTG monitoring in established labor.\n\nContraindications and Cautions:\n- Absolute contraindications for ECV include placenta previa, antepartum hemorrhage, severe preeclampsia, and abnormal fetal dopplers.\n- Risk factors for planned vaginal breech birth include hyperextended neck on ultrasound, high or low estimated fetal weight, footling presentation, and evidence of antenatal fetal compromise.\n- Factors such as fetal hyperextended neck, high or low estimated fetal weight, footling presentation, and evidence of fetal compromise may require a caesarean section.\n- Maternal factors such as previous LSCS, raised BMI, maternal age >40 years, and other obstetric complications may also require a caesarean section.",
      "In pregnancies complicated by diabetes, maintaining maternal euglycemia during labor is crucial to reduce adverse outcomes. Glycemic targets should be 70-125 mg/dL, individualized based on diabetes type. Maternal hyperglycemia during labor can lead to fetal hypoxemia and neonatal hypoglycemia. Insulin pumps can be used during labor, with protocols for intravenous insulin available. Postpartum insulin dosing is typically 30-35% of antenatal doses, adjusted based on glucose levels. Breastfeeding may lower insulin requirements. Metformin is recommended for type 2 diabetes postpartum and is compatible with breastfeeding. Close glucose monitoring postpartum is essential. Gestational diabetes may not need medication postpartum. Follow-up testing for diabetes postpartum is advised. Subcutaneous correctional insulin is often sufficient for managing gestational diabetes during labor, with insulin infusion an option if needed.",
      "The clinical guideline on Blood Transfusion in Obstetrics provides recommendations for reducing the risk of transfusion in pregnant women. It includes guidelines for optimizing hemoglobin levels, diagnosing anemia, and managing obstetric hemorrhage with blood components. Strategies to minimize the use of banked blood, such as preoperative autologous blood deposit and intraoperative cell salvage, are discussed. The guideline emphasizes obtaining consent for blood transfusion, regular monitoring of blood group and antibody status, and using appropriate blood products during pregnancy and the postpartum period. The importance of managing obstetric hemorrhage with mechanical strategies and close monitoring of clotting tests is highlighted.",
      "Endometriosis, a chronic inflammatory condition in women of reproductive age, presents with pain and infertility. Diagnosis involves imaging and laparoscopy. Management includes hormone therapy and surgery, guided by symptoms and fertility desires. Infertility treatments like IUI and ART can be considered. Hormone therapy post-surgery aids in pain management. Avoid unnecessary treatments in asymptomatic cases. Monitoring involves follow-up and psychological support. Risks include cancer and adverse pregnancy outcomes. Early diagnosis and appropriate treatment improve outcomes. Surgical and medical interventions are essential, with shared decision-making. Adjunct therapies like acupuncture may be considered. Ovarian suppression is ineffective for fertility. Hormone therapy prevents recurrence. Aromatase inhibitors may benefit postmenopausal women. Monitoring parameters include symptom improvement and fertility outcomes. Tibolone is a safe alternative for hormone therapy in menopause. Diagnosis and management of abdominal and thoracic endometriosis differ. Genetic testing is for research. Endometriosis does not significantly increase cancer risk. Monitoring for ovarian malignancy may not be beneficial. Bilateral salpingo-oophorectomy is not recommended without additional risk factors. Shared decision-making is crucial for pain management. Vigilance is needed during pregnancy for complications.",
      "Summary:\n\nAssisted Vaginal Birth (RSCH PRH only) MP049 is a protocol for managing assisted instrumental vaginal births with the goal of mimicking spontaneous birth while minimizing morbidity. Key principles include professional judgment alongside protocol adherence. Indications and contraindications for operative vaginal birth are outlined, with a focus on reducing the need for such interventions. Risks of Ventouse and forceps deliveries are compared, and clear communication is emphasized for preparation. Informed consent, analgesia options, bladder care, hygiene, neonatal resuscitation, and perineal care protocols are detailed. Post-delivery documentation requirements and debriefing recommendations are provided. Monitoring parameters include timing and volume of first void, risk of urinary retention, and strategies for reducing urinary incontinence. Professional training in neonatal resuscitation and adherence to aseptic techniques are essential. Specific documentation requirements post-delivery and debriefing opportunities are emphasized for comprehensive care.",
      "**Summary:**\n\n**Clinical Conditions and Management:**\n- Diagnosis of endometriosis involves symptoms like dysmenorrhea and infertility, with laparoscopy as the gold standard.\n- Treatment options include NSAIDs, hormone therapies, and surgical excision preferred over ablation for pain relief.\n- Monitoring parameters focus on pain relief and recurrence post-treatment.\n\n**Diagnostic Criteria and Thresholds:**\n- Recurrence rates vary post-surgery, and nerve-sparing laparoscopy can reduce urinary retention risk.\n\n**Medical Interventions and Timing:**\n- Postoperative hormone therapy may be considered for pain management.\n\n**Monitoring Parameters:**\n- Quality of life and fertility outcomes guide surgical management decisions.\n- The Endometriosis Fertility Index (EFI) aids in reproductive options post-surgery.\n\n**Contraindications and Risk Factors:**\n- Complications in bowel endometriosis surgery, especially rectal surgery, are significant.\n- Recurrence rates post-surgery are procedure-dependent.\n\n**Quantitative Values and Cutoffs:**\n- Surgical considerations for infertility vary by endometriosis stage.\n- Limited benefit shown for certain medications in improving pregnancy rates.\n\n**Conclusion:**\n- Individualized treatment plans based on shared decision-making are essential.\n- Further research is needed on non-medical management strategies and ART outcomes in endometriosis-associated infertility.",
      "The NICE guideline on endometriosis diagnosis and management provides recommendations for healthcare professionals to effectively care for patients with this condition. It emphasizes individualized care based on symptoms, preferences, and priorities rather than solely on the stage of endometriosis. The guideline covers various aspects, including organization of care, information and support, diagnosis, pain management, surgical options, and fertility considerations. Additionally, it highlights the need for further research on alternative treatment options, the effectiveness of laparoscopic treatment for peritoneal endometriosis, lifestyle interventions, information and support interventions, and hormonal treatments' impact on fertility outcomes.",
      "Clinical Consensus No. 455 emphasizes the importance of fetal sex determination in obstetric ultrasound examinations and the respect for parental wishes regarding disclosure. Health care providers should make efforts to determine fetal sex during ultrasound exams and include a visible alert in reports if this information is present. The guideline highlights the significance of prenatal diagnosis of fetal genital anomalies and stresses the need for re-examination or referral if fetal sex cannot be determined. Ultimately, the guideline aims to ensure that fetal sex information is accurately communicated to patients and that their preferences are respected throughout the process.",
      "The clinical guideline on epilepsy in pregnancy emphasizes the importance of proper diagnosis and management of epilepsy during pregnancy. It stresses the need for specialized care from a neurologist, assessment of risks to both mother and baby, and individualized treatment plans based on fetal risk and seizure control. The guideline also addresses the impact of antiepileptic drugs on pregnancy outcomes, the importance of folic acid intake, and the need for regular antenatal care with an epilepsy care team. Additionally, it provides recommendations for managing seizures during labor, monitoring AED levels, and postnatal care to ensure the well-being of both the mother and baby. Effective contraception is highlighted as crucial for stabilizing the condition and optimizing outcomes for women with epilepsy. Healthcare providers are encouraged to provide evidence-based information and support to empower women with epilepsy to make informed choices regarding their pregnancy and epilepsy management.",
      "Guideline for preventing malaria in pregnancy for UK residents visiting endemic areas emphasizes the risks, complications, and prevention strategies. Pregnant women are at higher risk of malaria complications, including maternal mortality and pregnancy loss. Recommendations include postponing travel if possible, using chemoprophylaxis like mefloquine in certain areas, and seeking prompt diagnosis and treatment. Standby treatment instructions should be given for suspected malaria, with quinine and clindamycin recommended for pregnant women. Individual patient needs should be considered when following these guidelines.",
      "This clinical guideline focuses on the initial management of chronic pelvic pain in women. It emphasizes the importance of a thorough assessment to identify contributing factors and develop a comprehensive management plan. The guideline highlights the need for a partnership between the clinician and the woman to establish functional goals and monitor progress. Diagnostic criteria for conditions like IBS are discussed, along with the importance of considering non-gynecological components of pain. Various therapeutic options, including hormonal treatments and physical therapy, are recommended. The guideline also addresses the role of psychological factors and past trauma in chronic pelvic pain. Referral to specialists and appropriate investigations are suggested for cases where pain is not adequately controlled.",
      "Uterine fibroids are common in reproductive-age females and can cause symptoms like abnormal uterine bleeding, pressure, fertility issues, and pain. Treatment options include expectant management, hysteroscopic fibroid resection, medical therapy, GnRH agonists, uterine artery embolization, and various surgical options based on symptom severity and patient preference. Different medications like elagolix, relugolix, and linzagolix have shown efficacy in reducing menstrual bleeding. Laparoscopic myomectomy is preferred over open abdominal myomectomy due to less blood loss and lower complication rates. Patients desiring fertility can consider myomectomy or hysteroscopic myomectomy. UAE, hysterectomy, and GnRH analogs are options for patients not desiring future fertility or with bulk/pain symptoms.",
      "Bladder Pain Syndrome (BPS) Management:\n- Initial assessment: thorough history, physical exam, bladder diary, and UTI testing\n- Diagnostic criteria: validated symptom scores, exclusion of other conditions\n- Management: dietary modifications, stress management, analgesia, intravesical treatments if needed\n- Monitoring: symptom scores, response to treatment\n- Contraindications: avoid certain medications and procedures in pregnancy\n- Quantitative values: symptom scores, medication dosages\n\nPelvic Pain Investigation:\n- Assessment: history of abuse, physical exam ruling out specific conditions\n- Diagnostic criteria: exclusion of other causes, baseline investigations\n- Management: conservative treatments, pharmacological options, multimodal therapy\n- Monitoring: response to treatment, multidisciplinary input\n- Contraindications: avoid specific medications and procedures\n- Quantitative values: symptom scores, medication dosages\n\nPregnancy and BPS:\n- Treatment options: safe medications like oral amitriptyline, intravesical heparin\n- Monitoring: symptom changes during pregnancy, genetic predisposition\n- Contraindications: avoid DMSO, consider safety of medications during pregnancy\n- Quantitative values: medication dosages, symptom severity assessments\n\nReferences:\n- Shorter B, Lesser M, Moldwin RM, Kushner L. J Urol 2007;178:145–52\n- Cervigni M, Natale F. Int J Urol 2014;21 Suppl 1:85–8\n- Foster HE Jr, Hanno PM, et al. J Urol 2010;183:1853–8\n- van Ophoven A, Pokupic S, et al. J Urol 2004;172:533–6\n- Nickel JC, Moldwin R, et al. BJU Int 2009;103:910–8\n\nClinical guidelines provide standardized recommendations for BPS management, emphasizing individual patient needs and resource availability. Evidence-based grading guides decision-making, highlighting areas for further research.",
      "Diagnosis and Presentation:\n- Pregnancy of unknown location (PUL) is diagnosed when a patient with a positive pregnancy test has a transvaginal ultrasound showing neither an intrauterine pregnancy (IUP) nor an ectopic pregnancy.\n- Patients with PUL may be asymptomatic or present with symptoms of early pregnancy or ectopic pregnancy.\n- Differential diagnosis includes early IUP, ectopic pregnancy, molar pregnancy, and rare entities.\n\nTreatment and Management:\n- Initial evaluation involves history, physical examination, and transvaginal ultrasound.\n- Further diagnostic workup is based on ultrasound findings.\n- Serial serum human chorionic gonadotropin (hCG) measurements and transvaginal ultrasound assessments are done for selected patients.\n- Management depends on hemodynamic stability and pregnancy desires. Hemodynamically unstable patients require immediate surgical intervention, while stable patients may undergo expectant management with regular hCG and ultrasound assessments.\n\nMonitoring Requirements:\n- Monitor serial serum hCG levels.\n- Monitor transvaginal ultrasound assessments.\n- Monitoring frequency should be based on clinical judgment.\n\nContraindications and Cautions:\n- Hemodynamically unstable patients are contraindicated for expectant management.\n- Uncommon or rare etiologies such as malignancy, pituitary hCG production, and heterophilic antibodies are cautionary factors.\n- Patients with desired pregnancies require special considerations in management.",
      "Guideline emphasizes prompt diagnosis and treatment of malaria in pregnancy to prevent mortality. Symptoms include flu-like illness. Non-falciparum malaria is treated with chloroquine; severe falciparum cases require hospitalization and IV artesunate or quinine. Regular monitoring is crucial. IV artesunate is recommended for severe cases, seek expert consultation if needed. Clindamycin is not recommended in pregnancy. WHO suggests artemisinin-based therapy in later trimesters. Chloroquine and sulfadoxine-pyrimethamine are not recommended due to resistance. Radical cure with primaquine is not advised in pregnancy. Plasmodium falciparum can persist in the placenta post-treatment, necessitating careful monitoring.",
      "The clinical guideline on Female Genital Mutilation (FGM) emphasizes the importance of healthcare professionals being aware of the complications and legal aspects of FGM. It highlights the need for mandatory reporting of FGM in girls under 18, clear referral pathways, and training for gynaecologists and midwives. De-infibulation should be offered before pregnancy, and postnatal care should include follow-up if not performed during delivery. The guideline also addresses the importance of a safe and private environment, psychological assessment, and vigilance for clinical signs of recent FGM. Data collection on FGM in the UK is essential for tracking care for affected women.",
      "Recommendations for intrahepatic cholestasis of pregnancy (ICP) management include considering ICP in pregnant women with itching and bile acid concentration of 19 micromol/L or higher, discussing severe cases with a hepatologist, and confirming postnatal resolution. Stillbirth risk increases with peak bile acid concentrations, especially in twin pregnancies. Ultrasound and CTG do not predict or prevent stillbirth in ICP. Ursodeoxycholic acid is not routinely recommended for adverse perinatal outcomes in ICP. Continuous fetal monitoring is advised for women with peak bile acids of 100 micromol/L or more. Follow-up postpartum is essential to confirm resolution. Future research should focus on prognostic tools, testing for gestational diabetes, and effective treatments for itching and adverse perinatal outcomes in ICP.",
      "The SOGC Clinical Practice Guideline No. 451 addresses the management of asymptomatic endometrial thickening in postmenopausal women. It emphasizes that routine pelvic ultrasound is not recommended for screening for endometrial cancer and that most patients with endometrial cancer present with postmenopausal bleeding. The guideline provides recommendations for further investigations based on individual risk factors and ultrasound findings, with endometrial thickness <11 mm associated with a low risk of malignancy. It also discusses the impact of hormone therapy on endometrial health and provides recommendations for preoperative ripening of the cervix before hysteroscopy. The guideline highlights the importance of individualized care and appropriate management based on specific patient factors.",
      "The NICE antenatal care guideline emphasizes the importance of involving partners in care decisions, providing comprehensive care for pregnant women, and addressing common problems during pregnancy. Recommendations include assessing risk factors, discussing fetal movements, offering support for women with increased risk factors, and providing information on various aspects of antenatal care. The guideline also covers interventions for nausea and vomiting, heartburn, and pelvic girdle pain. It highlights the importance of addressing inequalities in care, discussing sleep positions to reduce stillbirth risk, and providing peer support services. The guideline aims to improve antenatal care practices without major changes in practice.",
      "The clinical guideline on the management of Gestational Trophoblastic Disease emphasizes the importance of recognizing the symptoms and signs of molar pregnancies, such as irregular vaginal bleeding and positive pregnancy tests. The definitive diagnosis is made through histological examination, and suction curettage is the preferred method for removal. Women with persistently elevated hCG levels should be referred to a GTD center, and those with suspected GTN should be investigated promptly. Follow-up care is crucial, and women are advised to wait before conceiving again. Support and resources are available for those affected by GTD. Research is ongoing to improve outcomes and management strategies.",
      "The clinical guideline provides key recommendations for the diagnosis and management of preterm premature rupture of membranes (PPROM). It emphasizes the importance of accurate diagnosis through maternal history and speculum examination, as well as the use of IGFBP-1 or PAMG-1 tests when necessary. Antibiotics, corticosteroids, and magnesium sulfate are recommended for appropriate cases, with neonatologist involvement and expectant management until 37 weeks gestation. The guideline also highlights the need for emotional support and further research in PPROM management. Gynaecologists are encouraged to refer to relevant resources and support groups for additional information. The guideline was developed by a team of healthcare professionals and will be reviewed periodically for updates.",
      "RCOG Green-top Guideline No. 49 focuses on preventing entry-related gynaecological laparoscopic injuries, aiming to reduce serious complications associated with laparoscopic surgery. Surgeons are advised to be trained in safe techniques, insert the primary trocar at 90 degrees to the skin, and maintain intra-abdominal pressure before insertion. Alternative entry techniques and sites, such as Palmer's point, are recommended in certain cases. Special care is needed for entry in specific patient populations. Documentation of counseling and reporting adverse events are essential. The guideline emphasizes the importance of appropriate training, supervision, and experience in laparoscopic surgery, with recommendations based on expert opinions and clinical experiences.",
      "Intrahepatic cholestasis of pregnancy is a liver condition that can have serious consequences for both the mother and the fetus. It is characterized by itching and elevated bile acids, and can lead to preterm birth, neonatal respiratory distress, and stillbirth. Treatment involves medication to alleviate symptoms and early delivery based on bile acid levels. Recurrence in future pregnancies is common, and monitoring and delivery timing should be based on bile acid levels. Close monitoring during labor is recommended, and resolution of symptoms should be confirmed postpartum. Patients and family members are at higher risk for ICP in future pregnancies, and contraceptive options should be discussed.",
      "The clinical guideline on Ectopic pregnancy and miscarriage: diagnosis and initial management focuses on improving the diagnosis and management of ectopic pregnancy and miscarriage in women with early pregnancy complications. Recommendations include providing support and information with dignity, offering early pregnancy assessment services 7 days a week, and recognizing symptoms of ectopic pregnancy for prompt referral. The guideline emphasizes the importance of offering systemic methotrexate or surgery for tubal ectopic pregnancy based on specific criteria. Further research is needed to assess the psychological impact of different interventions on women's emotional recovery. Standardizing practices based on evidence will improve diagnosis and reduce risks, ultimately improving the quality of care for women experiencing early pregnancy loss.",
      "Diagnosis and Presentation:\n- Pregnancy loss, or miscarriage, is defined as a nonviable intrauterine pregnancy up to 20 weeks of gestation.\n- Early pregnancy loss occurs in the first trimester and is the most common type.\n- Diagnosis is confirmed with transvaginal ultrasound evaluation.\n- Ultrasound criteria for diagnosis include:\n  - Gestational sac 25 mm in mean diameter without a yolk sac or embryo.\n  - Embryo with a CRL 27 mm without cardiac activity.\n  - Absence of an embryo with a heartbeat in 22 weeks from a prior ultrasound showing a gestational sac without a yolk sac.\n  - After a pelvic ultrasound showed a gestational sac with a yolk sac, absence of an embryo with a heartbeat in 21 days.\n  - Initial criteria for nonviable early pregnancy include CRL of 5 mm without cardiac activity and an empty gestational sac measuring 16 mm in mean diameter.\n- Challenging scenarios in early pregnancy assessment include gestational duration discrepancy, multiple gestations, and pregnancy of unknown location.\n- Additional ultrasound findings suggestive of non-viable pregnancy include expanded or empty amnion.\n- Findings suggestive of poor outcome include irregularly shaped gestational sac, moderate or large subchorionic hematoma, and chorionic bump.\n- Findings consistent with live pregnancy include a gestational sac with a yolk sac only and a normal pregnancy with amnion.\n\nTreatment and Management:\n- Guidelines recommend transvaginal ultrasonographic diagnosis of pregnancy failure in a woman with an intrauterine pregnancy of uncertain viability.\n- Diagnosis of early pregnancy loss is made using transvaginal ultrasound.\n- Various ultrasound criteria are used to diagnose pregnancy loss.\n\nMonitoring Requirements:\n- Monitoring of gestational sac diameter and cardiac activity may be needed.\n- Frequency of monitoring may vary based on clinical context.\n\nContraindications and Cautions:\n- No specific contraindications mentioned.\n- Risk factors include varying levels of stringency in ultrasound techniques and the consideration of false-positive rates in diagnosis.",
      "The clinical guideline focuses on the laparoscopic management of non-obstetric, abdominal conditions in pregnancy, such as acute appendicitis, gallbladder disease, and benign adnexal tumors. It highlights the importance of experienced laparoscopists to ensure maternal and fetal safety, as studies have shown that laparoscopy is safe with no increased risk of adverse outcomes compared to open surgery. Factors such as expertise, infrastructure, gestation, and patient preference should be considered when choosing the type of surgery. Maternal and fetal outcomes are generally good for laparoscopic surgery in pregnancy, with skilled surgeons having better outcomes. Urgent surgery should not be delayed, and both laparoscopic and open surgery are acceptable options.",
      "The clinical guideline provides guidance for health professionals caring for women of childbearing age with breast cancer. It emphasizes the importance of a multidisciplinary team approach for optimal management. Women diagnosed during pregnancy have a similar prognosis to non-pregnant women, but treatment should consider tumor characteristics and pregnancy stage. Non-hormonal contraception is recommended after treatment, and women planning pregnancy should consult with their healthcare providers. Pregnancy after breast cancer does not adversely affect long-term survival, and women can be reassured about the risk of malformations in children conceived after treatment. Fertility preservation options should be discussed before treatment, and assisted reproduction may be considered if needed.",
      "Amniocentesis and chorionic villus sampling are prenatal diagnostic tests with a low risk of miscarriage. Amniocentesis should be performed after 15 weeks of gestation, while CVS should be done after 10 weeks. Multiple pregnancies slightly increase the risk of miscarriage. Screening for blood-borne viruses is important before invasive tests. Proper training and good practice are crucial to reduce risks. Severe maternal sepsis is rare, and infection can occur from various sources. Third-trimester amniocentesis may be offered for specific fetal conditions. Antiretroviral treatment should be optimized for HIV-positive women. The risk of mother-to-child transmission of HBV increases with higher viral loads. There is no evidence of transmission risk for HCV following amniocentesis.",
      "The clinical guideline for the Prevention of Early-onset Neonatal Group B Streptococcal Disease emphasizes the importance of clinical risk factors for GBS disease and provides recommendations for intrapartum antibiotic prophylaxis (IAP) for known carriers. While routine testing for GBS in pregnancy is not recommended due to potential inaccuracies and risks, IAP should be offered to women with previous GBS infection or bacteriuria. Immediate IAP is recommended for known carriers at term, and broad-spectrum antibiotics should be considered for pyrexial women in labor. Babies showing signs of EOGBS disease should be promptly treated, and breastfeeding is encouraged regardless of GBS status. Close monitoring is advised for babies of mothers who decline IAP. The guideline also addresses various studies related to GBS colonization, antibiotic treatment, and maternal and infant outcomes, providing a comprehensive overview of evidence-based recommendations. It is important to consider individual patient data and local protocols when implementing these guidelines.",
      "Diagnosis and Presentation:\n- Antiretroviral therapy (ART) initiation during pregnancy and lifelong treatment for pregnant women living with HIV\n- Assessment of antenatal and postnatal depression\n- Sexual health screening for newly diagnosed pregnant women with HIV\n- Continuation of effective combination antiretroviral therapy (cART) for women conceiving on cART\n- Recommendation of Tenofovir DF or abacavir with emtricitabine or lamivudine as nucleoside backbone\n- Deferral of invasive prenatal diagnostic testing until HIV status is known\n- Mode of delivery based on maternal viral load\n\nTreatment and Management:\n- Multidisciplinary antenatal HIV care\n- Peer support for pregnant women living with HIV\n- HIV resistance testing before treatment initiation\n- Regular CD4 cell counts and HIV viral load tests for women conceiving on cART\n- Initiation of treatment for pregnant women with baseline viral load >100,000 HIV RNA copies/mL by the start of the second trimester\n- Integrase inhibitor-based regimens for certain patients\n- Discussion of dolutegravir use in pregnancy considering risks of neural tube defects\n- Monitoring of liver function tests and interventions for unsuppressed viral load\n- Postpartum care including cART continuation, mental health evaluation, and contraception discussion\n\nMonitoring Requirements:\n- Monitoring of CD4 cell counts throughout pregnancy\n- Regular HIV viral load tests during pregnancy\n- Monitoring of liver function tests\n- Monitoring of infant HIV status with molecular diagnostics and antibody testing\n\nContraindications and Cautions:\n- Deferral of invasive prenatal diagnostic tests until viral load is <50 HIV RNA copies/mL\n- Immediate testing required if viral load is ≥400 copies/mL, with cART and nevirapine administration\n- Vaginal delivery supported for viral load <50 copies/mL, cesarean section recommended for viral load ≥400 copies/mL\n- Postpartum zidovudine infusion recommended for viral load >1000 copies/mL\n- Breastfeeding supported for virologically suppressed women, formula feeding recommended otherwise\n\nDiagnosis and Presentation:\n- Increased risk of preterm delivery with protease inhibitors vs nucleoside reverse transcriptase inhibitor-based HAART during pregnancy\n- No difference in risk of preterm birth between lopinavir/ritonavir vs efavirenz-based ART\n- Unique management considerations for HIV, chronic HBV infection, and pregnancy\n- Routine monitoring of liver function tests throughout pregnancy and postpartum\n- Management of women with both HCV and HIV during pregnancy\n- Fetal ultrasound imaging recommended regardless of maternal HIV status\n- Mode of delivery based on plasma viral load results at 36 weeks\n\nTreatment and Management:\n- Referral to specialist for comprehensive care for HIV, chronic HBV infection, and pregnancy\n- Tenofovir DF, emtricitabine, and lamivudine as backbone for HIV/HBV co-infection treatment\n- Consideration of tenofovir alafenamide after first trimester\n- Maternal cART with prompt neonatal immunoprophylaxis for preventing vertical transmission of HBV\n- Immediate neonatal immunisation within 24 hours of delivery\n- Zidovudine monotherapy or combination post-exposure prophylaxis (PEP) for infants based on risk level\n- Co-trimoxazole prophylaxis for HIV-infected infants\n- Breastfeeding advice for women with HIV\n\nMonitoring Requirements:\n- Regular monitoring of liver function tests throughout pregnancy and postpartum\n- Regular monitoring of plasma viral load for risk level determination and treatment approach\n- Monthly clinic visits for HIV RNA viral load testing during and after breastfeeding\n- Disclosure of HIV status to partner/family and healthcare provider\n- Molecular diagnostics for HIV infection in infants\n\nContraindications and Cautions:\n- Relative contraindication of liver biopsy and hepatic elastometry during pregnancy\n- Contraindication of ribavirin in pregnancy and avoidance in male partners of pregnant women\n- Immediate discontinuation of ribavirin if pregnancy occurs during treatment\n- Limited duration of PEP for infants, not exceeding 2 weeks for very low-risk or 4 weeks for low-risk infants even if breastfed",
      "Management of inherited bleeding disorders in pregnancy involves monitoring and maintaining factor levels, offering prenatal diagnosis for severe hemophilia carriers, utilizing treatments like tranexamic acid and factor concentrates, and providing antenatal care by a multidisciplinary team. Postpartum management includes maintaining factor levels and monitoring for bleeding. Neonatal management involves diagnostic testing, administering vitamin K, and considering prophylaxis in severe cases. Women with VWD have an increased bleeding risk during pregnancy, and intrapartum management should focus on maintaining VWF activity levels. Factor XI deficiency poses risks of PPH and can be managed with tranexamic acid, factor XI concentrate, and FFP. Tailoring treatment for rare bleeding disorders involves adjusting interventions based on individual bleeding patterns. Genetic testing for at-risk fetuses can be done through CVS or amniocentesis, and PGD is an option for couples at risk of heritable disorders. Close monitoring and individualized care are essential during pregnancy and delivery for women with inherited bleeding disorders.",
      "The clinical guideline on the care of women with obesity in pregnancy, released in November 2018, emphasizes the importance of pre-pregnancy care, antenatal care, information giving during pregnancy, risk assessment, and special considerations for screening, diagnosis, and management of maternal disease in women with obesity. Recommendations include providing information on risks associated with obesity, monitoring weight and height, screening for gestational diabetes, and offering mental health screening. The guideline also addresses fetal surveillance, planning for labor and birth, anesthetic and obstetric outcomes, and postnatal care. It highlights the need for multidisciplinary care and tailored support for women with obesity before, during, and after pregnancy.",
      "This clinical guideline on Birth After Previous Caesarean Birth provides recommendations for antenatal care, counselling, and decision-making for women with prior cesarean deliveries. It discusses the suitability of planned vaginal birth after cesarean (VBAC) for most women with a single prior cesarean, contraindications to VBAC, and factors influencing VBAC success rates. The guideline emphasizes the importance of continuous monitoring during VBAC, the risks associated with induction or augmentation of labor, and the timing and perioperative care for elective repeat cesarean sections. It also highlights the need for personalized decision-making, patient counseling, and further research on predicting successful VBAC outcomes.",
      "The NICE guideline on inducing labor covers the circumstances, methods, assessment, monitoring, pain relief, and complications of labor induction to improve care for pregnant women. Recommendations include discussing birth preferences early, offering expectant management for uncomplicated pregnancies, and considering individual circumstances and risks. The guideline addresses specific scenarios such as preterm prelabor rupture of membranes, breech position, and fetal growth restriction. Monitoring fetal wellbeing and managing complications like hyperstimulation are crucial during induction. Research recommendations focus on optimal timing and management of preterm rupture of membranes. The guideline aims to provide information and support for informed decision-making in labor induction.",
      "The clinical guideline on Cervical Cerclage provides recommendations for the insertion of cerclage in women at risk of preterm birth and second trimester fetal loss. It outlines key recommendations for history-indicated and ultrasound-indicated cerclage, as well as emergency cerclage in specific situations. The guideline emphasizes the importance of individualized care and informed decision-making, highlighting potential complications and contraindications to cerclage insertion. It also discusses the types of cerclage techniques, suture materials, and adjuvant management strategies. The guideline calls for further research in certain areas to improve understanding and outcomes related to cerclage procedures.",
      "The clinical guideline on Assisted Vaginal Birth emphasizes the importance of preparation, assessment, and expertise in performing assisted vaginal births. It recommends continuous support during labor, different positions during the second stage of labor, and delayed pushing in certain situations to reduce the need for assisted birth. The guideline outlines when to recommend or contraindicate assisted vaginal birth, conditions for safe practice, and the importance of obtaining consent. It also addresses aftercare, documentation, and the importance of training and supervision in performing assisted births. The guideline highlights the risks, benefits, and techniques associated with vacuum and forceps deliveries, as well as the importance of informed decision-making and psychological support for women undergoing assisted births.",
      "This clinical guideline on Chickenpox in Pregnancy focuses on prevention and management strategies for pregnant women. It recommends varicella vaccination for non-immune women, avoiding contact with chickenpox, and testing for VZV immunity if exposed. Treatment with VZIG and aciclovir is advised for non-immune pregnant women with chickenpox. Risks to the fetus and newborn are discussed, with individualized delivery plans for pregnant women with chickenpox. Screening for VZV immunity is not routinely recommended in the UK. Early notification to healthcare providers, isolation, and careful monitoring are essential for pregnant women with chickenpox. Prophylaxis with VZIG is crucial for newborns exposed to chickenpox. Further research and support resources are available for managing chickenpox in pregnancy.",
      "External Cephalic Version (ECV) is a procedure to turn a breech baby to a head-down position, reducing the chances of a caesarean section. It should be offered at term from 37 weeks of gestation, with tocolysis potentially improving success rates. Regional analgesia may be considered for pain relief during the procedure. ECV should only be performed by trained practitioners, and women should be informed of the risks and benefits. Further research is needed to improve ECV outcomes and methods to increase uptake and success rates. ECV has a low complication rate and does not increase the risk of intrauterine death.",
      "Prelabor rupture of membranes (PROM) at term involves the early rupture of fetal membranes before contractions. Management decisions include inducing labor to reduce infection risk or waiting for spontaneous labor. Oxytocin induction is preferred for uncomplicated cases, while expectant management is an option for low-risk patients. Hospitalization is recommended to monitor for complications. Antibiotic prophylaxis is used selectively. Induction with oxytocin reduces neonatal infections. GBS status influences antibiotic use. Expectant management includes infection and fetal monitoring. Monitoring and decisions should be based on individual risk assessment.",
      "Antenatal corticosteroids are recommended for women at risk of preterm birth to reduce perinatal and neonatal death, respiratory distress syndrome, and other adverse outcomes. They should be offered to women between 24+0 and 34+6 weeks' gestation, including those with twins and triplets. Corticosteroids should not be delayed if birth is necessary for the health of the woman or baby. Careful consideration is needed for the use of corticosteroids in late preterm births, multiple pregnancies, diabetes, and other special populations. Research is ongoing to determine the safety and effectiveness of corticosteroids in various conditions, with recommendations for future studies provided.",
      "Diagnosis and Presentation:\n- Suspected or actual baby abduction in the hospital setting\n- Staff in maternity, portering, security, and switchboard departments involved\n- Immediate actions: informing security, contacting the police, coordinating the response\n\nTreatment and Management:\n- Move parents to a private area\n- Check identification bands\n- Reassure mothers\n- Cooperate with the police\n- Manage media inquiries through Trust's Communications Manager and senior management\n\nMonitoring Requirements:\n- Audit the guidance after each reported abduction incident\n\nContraindications and Cautions:\n- Failure to follow the protocol in case of suspected or actual baby abduction\n- Non-adherence to visiting hours and restrictions\n\nRisk Factors:\n- Lack of staff adherence to guidance and protocols\n- Inadequate training on baby abduction risks and actions",
      "This document provides evidence-based guidance for managing anaemia during pregnancy and the postnatal period. It covers causes, consequences, screening, and treatment options for iron deficiency, including dietary advice, oral iron replacement, and intravenous iron therapy. Monitoring hemoglobin levels is crucial, and treatment should be tailored based on individual needs and responses. Special considerations are outlined for high-risk individuals and those with contraindications for certain treatments. Prioritizing iron infusion for pregnant individuals with low hemoglobin levels approaching term is recommended to reduce the risk of postpartum complications. Blood transfusion should be considered cautiously, with informed consent and documentation of discussions.",
      "The clinical guideline for the Diagnosis and Management of Ectopic Pregnancy emphasizes the importance of transvaginal ultrasound for diagnosis, visualizing adnexal masses for tubal ectopic pregnancies, and using serum beta-human chorionic gonadotrophin levels for management planning. Specific criteria exist for diagnosing various types of ectopic pregnancies, with surgical, pharmacological, and conservative treatment options available. Long-term fertility prospects should be discussed with patients, and support and counseling should be offered during treatment. Providers should have appropriate training for ultrasound-guided needle techniques, and anti-D immunoglobulin should be offered to women with ectopic pregnancies. The guideline also addresses the management of different types of ectopic pregnancies and provides recommendations for future studies and auditable topics.",
      "Laparoscopic hysterectomy is a safe and effective option for endometrial cancer when proper clinical governance, consent, and audit arrangements are in place. Patient selection by a multidisciplinary gynecological oncology team is crucial. Advanced laparoscopic skills are necessary, and additional training is recommended. The procedure offers a less invasive approach with shorter recovery times compared to open surgery. Conversion to laparotomy rates may vary, but postoperative complications are generally lower with laparoscopic hysterectomy. More data on long-term outcomes are needed for future evaluations.",
      "This guideline provides recommendations for the assessment and management of suspected ovarian masses in premenopausal women. It emphasizes the importance of early diagnosis and referral to a gynaecological oncologist for suspicious cases. Conservative management and laparoscopic techniques are recommended for benign masses, with specific guidelines for follow-up and surgical intervention based on the size and characteristics of the mass. Serum CA-125 levels and ultrasound findings are key factors in assessing the risk of malignancy, with additional risk assessment tools available. The guideline also addresses the role of laparoscopic surgery in managing ovarian masses, highlighting the importance of experienced surgeons and minimizing spillage of cyst contents to prevent potential malignancy.",
      "Antepartum haemorrhage (APH) is a significant complication of pregnancy, with placenta praevia and placental abruption being the main causes. It is associated with maternal and perinatal morbidity and mortality, and prompt clinical assessment and management are crucial. Triage, maternal stabilization, and investigations are important steps in the management of APH. Delivery may be necessary in cases of maternal or fetal compromise, with caesarean section typically used for placenta praevia. Postpartum hemorrhage should be anticipated, and appropriate blood products should be available for massive APH cases. Continuous fetal monitoring and neonatal assessment are essential for optimal outcomes. Future research should focus on interventions to prevent placental abruption and optimal timing of delivery in cases of unexplained APH.",
      "A guideline for managing unscheduled bleeding on hormone replacement therapy (HRT) emphasizes assessing women for endometrial cancer risk factors, investigating bleeding patterns, and adjusting HRT to reduce episodes. Recommendations include assessing compliance, considering low-dose preparations, and offering alternative progestogens or non-hormonal options based on individual factors. Endometrial assessment and management options are provided, with recommendations for adjusting HRT based on ultrasound findings and endometrial histology. Referral for ultrasound is advised in certain cases, and surgical options like hysteroscopic myomectomy or endometrial ablation may be considered. The document highlights the importance of individualized care and efficient resource utilization in managing unscheduled bleeding on HRT.",
      "This booklet provides comprehensive information on endometriosis, a chronic disease affecting women. It covers symptoms, diagnosis, and treatment options such as medication, hormonal therapy, and surgery. It also addresses the impact of endometriosis on fertility and discusses options for enhancing fertility. The importance of communication with a doctor in developing a suitable treatment plan is emphasized. The booklet also includes information on various endometriosis organizations for additional support. It is important to note that the information provided is for general knowledge and should not replace medical advice.",
      "The clinical guideline for the Management of Genital Herpes in Pregnancy provides recommendations for healthcare professionals on the care of pregnant women with genital herpes simplex virus infection. It covers antenatal, intrapartum, and postnatal care, including the use of aciclovir for treatment and prevention of neonatal herpes transmission. The guideline recommends vaginal delivery for most cases, with caesarean section advised for women with third trimester acquisition of herpes. It also addresses the management of recurrent herpes and the importance of preventing postnatal transmission. Stakeholder involvement and a comprehensive literature search informed the development of this guideline to ensure evidence-based recommendations for the management of genital herpes in pregnancy.",
      "Recommendations for outpatient hysteroscopy include providing written information before the appointment, offering various analgesic options, avoiding routine conscious sedation, and using vaginoscopy as the standard technique. Mechanical hysteroscopic tissue removal systems are preferred, and saline should be instilled at low pressure for optimal visualization. Cervical preparation with prostaglandins can be considered in selected cases. Flexible hysteroscopes and smaller-diameter instruments are associated with less pain and better outcomes. Monitoring for adverse events and ensuring informed consent are crucial. Studies have evaluated pain management methods and cervical preparation efficacy in outpatient hysteroscopy. Different hysteroscope types and medications can impact patient experience and procedure success."
    ]
  }
}